In this issue:
Effect of sequestosome 1 mutations on development of PDB
Romosozumab in postmenopausal women with osteoporosis
Denosumab + high dose teriparatide for postmenopausal osteoporosis
BMD changes after prophylactic bilateral salpingo-oophorectomy in BRCA carriers
Genetic predisposition to increased serum calcium, BMD & fracture risk
High-dose vitamin D supplementation effect on BMD & bone strength
Vitamin D deficiency associated with cortical bone loss & fractures in the elderly
Fracture risk following intermission of osteoporosis therapy
Long-term denosumab restores cortical bone loss & reduces fracture risk
Dapagliflozin attenuates hyperglycaemia-related osteoporosis in ZDF rats
A novel targeted fracture repair agent
Please login below to download this issue (PDF)